Advanced Medical Isotope Corporation (OTCMKTS:RDGL) Short Interest Down 87.4% in August

Advanced Medical Isotope Corporation (OTCMKTS:RDGL) saw a significant decrease in short interest in August. As of August 31st, there was short interest totaling 10,391 shares, a decrease of 87.4% from the August 15th total of 82,653 shares. Based on an average daily volume of 1,483,590 shares, the short-interest ratio is currently 0.0 days. Approximately 0.0% of the shares of the stock are short sold.

Advanced Medical Isotope Price Performance

Shares of Advanced Medical Isotope stock opened at $0.05 on Friday. The firm has a market cap of $24.50 million, a P/E ratio of -4.96 and a beta of -0.72. The firm has a 50 day simple moving average of $0.06 and a 200 day simple moving average of $0.07. Advanced Medical Isotope has a fifty-two week low of $0.04 and a fifty-two week high of $0.12.

About Advanced Medical Isotope

Vivos Inc, a radiation oncology medical device company, develops brachytherapy devices for the treatment of non-resectable tumors in the United States. It develops yttrium-90 based RadioGel device, an injectable particle-gel for brachytherapy radiation treatment of cancerous tumors in people and animals; and IsoPet for the treatment of solid tumors in animals. The company was formerly known as Advanced Medical Isotope Corporation and changed its name to Vivos Inc in December 2017. Vivos Inc was incorporated in 1994 and is headquartered in Richland, Washington.